IQVIA Holdings Inc. $IQV Shares Acquired by Police & Firemen s Retirement System of New Jersey

Police & Firemen s Retirement System of New Jersey boosted its holdings in IQVIA Holdings Inc. (NYSE:IQV) by 1.6% during the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 26,588 shares of the medical research company’s stock after acquiring an additional 416 shares during the period. Police & Firemen s Retirement System of New Jersey’s holdings in IQVIA were worth $4,190,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also made changes to their positions in the stock. Brighton Jones LLC boosted its position in IQVIA by 244.4% during the 4th quarter. Brighton Jones LLC now owns 3,575 shares of the medical research company’s stock valued at $703,000 after purchasing an additional 2,537 shares during the period. Mutual of America Capital Management LLC boosted its holdings in shares of IQVIA by 7.5% during the first quarter. Mutual of America Capital Management LLC now owns 34,435 shares of the medical research company’s stock valued at $6,071,000 after acquiring an additional 2,405 shares during the period. CWM LLC grew its position in shares of IQVIA by 4.0% during the first quarter. CWM LLC now owns 12,039 shares of the medical research company’s stock worth $2,122,000 after acquiring an additional 460 shares during the last quarter. Massachusetts Financial Services Co. MA grew its position in shares of IQVIA by 0.9% during the first quarter. Massachusetts Financial Services Co. MA now owns 143,573 shares of the medical research company’s stock worth $25,312,000 after acquiring an additional 1,324 shares during the last quarter. Finally, Wealthfront Advisers LLC increased its holdings in shares of IQVIA by 7.4% in the 1st quarter. Wealthfront Advisers LLC now owns 4,310 shares of the medical research company’s stock worth $760,000 after acquiring an additional 296 shares during the period. 89.62% of the stock is currently owned by institutional investors and hedge funds.

IQVIA Trading Down 1.1%

IQVIA stock opened at $221.06 on Friday. IQVIA Holdings Inc. has a 1 year low of $134.65 and a 1 year high of $228.12. The firm’s 50 day moving average price is $202.72 and its two-hundred day moving average price is $178.71. The firm has a market cap of $37.65 billion, a price-to-earnings ratio of 30.32, a price-to-earnings-growth ratio of 2.47 and a beta of 1.34. The company has a debt-to-equity ratio of 2.03, a quick ratio of 0.70 and a current ratio of 0.70.

IQVIA (NYSE:IQV) last issued its earnings results on Tuesday, October 28th. The medical research company reported $3.00 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.98 by $0.02. IQVIA had a return on equity of 30.70% and a net margin of 8.07%.The business had revenue of $4.10 billion for the quarter, compared to analysts’ expectations of $4.07 billion. During the same period in the previous year, the firm posted $2.84 EPS. The company’s quarterly revenue was up 5.2% on a year-over-year basis. IQVIA has set its FY 2025 guidance at 11.850-11.950 EPS. On average, research analysts predict that IQVIA Holdings Inc. will post 10.84 EPS for the current fiscal year.

Insider Buying and Selling at IQVIA

In other news, insider Eric Sherbet sold 4,000 shares of IQVIA stock in a transaction on Wednesday, October 29th. The stock was sold at an average price of $219.70, for a total transaction of $878,800.00. Following the transaction, the insider owned 27,108 shares in the company, valued at approximately $5,955,627.60. The trade was a 12.86% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Corporate insiders own 1.60% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms have commented on IQV. Truist Financial restated a “buy” rating and issued a $265.00 target price (up previously from $235.00) on shares of IQVIA in a research report on Wednesday, October 29th. TD Cowen downgraded shares of IQVIA from a “buy” rating to a “hold” rating and upped their price objective for the stock from $206.00 to $215.00 in a report on Monday, November 3rd. BMO Capital Markets started coverage on shares of IQVIA in a research note on Thursday. They set an “outperform” rating and a $260.00 target price on the stock. Stifel Nicolaus boosted their price target on shares of IQVIA from $234.00 to $254.00 and gave the stock a “buy” rating in a research report on Wednesday, October 29th. Finally, Weiss Ratings reiterated a “hold (c)” rating on shares of IQVIA in a report on Wednesday, October 8th. Two research analysts have rated the stock with a Strong Buy rating, sixteen have issued a Buy rating and six have issued a Hold rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $241.00.

About IQVIA

IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.